Influence of single nucleotide polymorphisms in factor VIII and von Willebrand factor genes on plasma factor VIII activity: The ARIC Study

Blood

Volumn 119, Issue 8, 2012, Pages 1929-1934

  Campos, Marco ^a   Buchanan, Ashley ^b   Yu, Fuli ^a   Barbalic, Maja ^c   Xiao, Yang ^d   Chambless, Lloyd E ^b   Wu, Kenneth K ^e   Folsom, Aaron R ^f   Boerwinkle, Eric ^c   Dong, Jing Fei ^a,d  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b IL   (United States)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^d PUGET SOUND BLOOD CENTER   (United States)

^e NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^f UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9A; VON WILLEBRAND FACTOR;

AFRICA; AGE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENVIRONMENTAL FACTOR; EUROPE; FEMALE; GENE SEQUENCE; GENETIC CODE; HAPLOTYPE; HEREDITY; HUMAN; MALE; PRIORITY JOURNAL; PROMOTER REGION; RACE; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84857517603     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-10-383661     Document Type: Article

References (33)

1. Wood WI, Capon DJ, Simonsen CC, et al. Expression of active human factor VIII from recombinant DNA clones. Nature. 1984;312(5992):330- 337.
2. Vehar GA, Keyt B, Eaton D, et al. Structure of human factor VIII. Nature. 1984;312(5992):337-342. (Pubitemid 15209310)
3. Fay PJ, Haidaris PJ, Smudzin TM. Human factor VIIIa subunit structure. Reconstruction of factor VIIIa from the isolated A1/A3-C1-C2 dimer and A2 subunit. J Biol Chem. 1991;266(14):8957-8962. (Pubitemid 21906604)
4. Stel HV, van der Kwast TH, Veerman EC. Detection of factor VIII/coagulant antigen in human liver tissue. Nature. 1983;303(5917):530-532. (Pubitemid 13054621)
5. van der Kwast TH, Stel HV, Cristen E, Bertina RM, Veerman EC. Localization of factor VIIIprocoagulant antigen: an immunohistological survey of the human body using monoclonal antibodies. Blood. 1986;67(1):222-227. (Pubitemid 16167036)
6. Vlot AJ, Koppelman SJ, van den Berg MH, Bouma BN, Sixma JJ. The affinity and stoichiometry of binding of human factor VIII to von Willebrand factor. Blood. 1995;85(11):3150-3157.
7. Lollar P, Hill-Eubanks DC, Parker CG. Association of the factor VIII light chain with von Willebrand factor. J Biol Chem. 1988;263(21):10451-10455.
8. Menache D, Aronson DL, Darr F, et al. Pharmacokinetics of von Willebrand factor and factor VIIIC in patients with severe von Willebrand disease (type 3 VWD): estimation of the rate of factor VIIIC synthesis. Cooperative Study Groups. Br J Haematol. 1996;94(4):740-745. (Pubitemid 26308912)
9. Tuddenham EG, Lane RS, Rotblat F, et al. Response to infusions of polyelectrolyte fractionated human factor VIII concentrate in human haemophilia A and von Willebrand?s disease. Br J Haematol. 1982;52(2):259-267. (Pubitemid 12033978)
10. Hamer RJ, Koedam JA, Beeser-Visser NH, Bertina RM, van Mourik JA, Sixma JJ. Factor VIII binds to von Willebrand factor via its Mr-80,000 light chain. Eur J Biochem. 1987;166(1):37-43. (Pubitemid 17089108)
11. Foster PA, Fulcher CA, Marti T, Titani K, Zimmerman TS. A major factor VIII binding domain resides within the amino-terminal 272 amino acid residues of von Willebrand factor. J Biol Chem. 1987;262(18):8443-8446.
12. Takahashi Y, Kalafatis M, Girma JP, Sewerin K, Andersson LO, Meyer D. Localization of a factor VIII binding domain on a 34 kilodalton fragment of the N-terminal portion of von Willebrand factor. Blood. 1987;70(5):1679-1682. (Pubitemid 18026187)
13. Bahou WF, Ginsburg D, Sikkink R, Litwiller R, Fass DN. A monoclonal antibody to von Willebrand factor (vWF) inhibits factor VIII binding. Localization of its antigenic determinant to a nonadecapeptide at the amino terminus of the mature vWF polypeptide. J Clin Invest. 1989;84(1):56-61. (Pubitemid 19170094)
14. Hill-Eubanks DC, Parker CG, Lollar P. Differential proteolytic activation of factor VIII-von Willebrand factor complex by thrombin. Proc Natl Acad Sci U S A. 1989;86(17):6508-6512. (Pubitemid 19236309)
15. Chandler WL, Rodgers GM, Sprouse JT, Thompson AR. Elevated hemostatic factor levels as potential risk factors for thrombosis. Arch Pathol Lab Med. 2002;126(11):1405-1414. (Pubitemid 36237293)
16. Jenkins PV, O?Donnell JS. ABO blood group determines plasma von Willebrand factor levels: a biologic function after all? Transfusion. 2006; 46(10):1836-1844. (Pubitemid 44435738)
17. Orstavik KH, Magnus P, Reisner H, Berg K, Graham JB, Nance W. Factor VIII and factor IX in a twin population. Evidence for a major effect of ABO locus on factor VIII level. Am J Hum Genet. 1985;37(1):89-101. (Pubitemid 15138680)
18. Vlot AJ, Mauser-Bunschoten EP, Zarkova AG, et al. The half-life of infused factor VIII is shorter in hemophiliac patients with blood group O than in those with blood group A. Thromb Haemost. 2000;83(1):65-69. (Pubitemid 30045479)
19. Morange PE, Tregouet DA, Frere C, et al. Biological and genetic factors influencing plasma factor VIII levels in a healthy family population: results from the Stanislas cohort. Br J Haematol. 2005;128(1):91-99.
20. Gitschier J, Wood WI, Goralka TM, et al. Characterization of the human factor VIII gene. Nature. 1984;312(5992):326-330. (Pubitemid 15209308)
21. Poustka A, Dietrich A, Langenstein G, Toniolo D, Warren ST, Lehrach H. Physical map of human Xq27-qter: localizing the region of the fragile X mutation. Proc Natl Acad Sci U S A. 1991;88(19):8302-8306. (Pubitemid 21915344)
22. Levinson B, Kenwrick S, Lakich D, Hammonds G Jr, Gitschier J. A transcribed gene in an intron of the human factor VIII gene. Genomics. 1990;7(1):1-11. (Pubitemid 20267313)
23. Levinson B, Kenwrick S, Gamel P, Fisher K, Gitschier J. Evidence for a third transcript from the human factor VIII gene. Genomics. 1992;14(3):585-589.
24. Thompson AR. Structure and function of the factor VIII gene and protein. Semin Thromb Hemost. 2003;29(1):11-22. (Pubitemid 36250259)
25. Mancuso DJ, Tuley EA, Westfield LA, et al. Structure of the gene for human von Willebrand factor. J Biol Chem. 1989;264(33):19514-19527. (Pubitemid 20008053)
26. Campos M, Sun W, Yu F, et al. Genetic determinants of plasma von Willebrand factor antigen levels: a target gene SNP and haplotype analysis of ARIC cohort. Blood. 2011;117(19):5224-5230.
27. Folsom AR, Wu KK, Shahar E, Davis CE. Association of hemostatic variables with prevalent cardiovascular disease and asymptomatic carotid artery atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Arterioscler Thromb. 1993;13(12):1829-1836. (Pubitemid 23360570)
28. Conlan MG, Folsom AR, Finch A et al. Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Thromb Haemost. 1993;70(3):380-385. (Pubitemid 23254660)
29. Scheet P, Stephens M. A fast and flexible statistical model for large-scale population genotype data: applications to inferring missing genotypes and haplotypic phase. Am J Hum Genet. 2006;78(4):629-644.
30. Yip SP. Sequence variation at the human ABO locus. Ann Hum Genet. 2002;66(pt 1):1-27.
31. Eikenboom JC, Castaman G, Kamphuisen PW, Rosendaal FR, Bertina RM. The factor VIII/von Willebrand factor ratio discriminates between reduced synthesis and increased clearance of von Willebrand factor. Thromb Haemost. 2002;87(2):252-257. (Pubitemid 34139861)
32. Bagnall RD, Waseem NH, Green PM, Colvin B, Lee C, Giannelli F. Creation of a novel donor splice site in intron 1 of the factor VIII gene leads to activation of a 191 bp cryptic exon in two haemophilia A patients. Br J Haematol. 1999;107(4):766-771. (Pubitemid 30020148)
33. Smith NL, Chen MH, Dehghan A, et al. Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium. Circulation. 2010;121(12):1382-1392.